Tag Archives: mercaptopurine

Janssen Biotech FDA approval Simponi Ulcerative Colitis

Janssen Biotech FDA approval Simponi Ulcerative Colitis Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral aminosalicylates, oral corticosteroids, azathioprine, or 6-mercaptopurine. The first and only subcutaneously administered anti-tumor …